Arrangement and Architecture of Tumor-Infiltrating Lymphocyte on H&E Slides Predict OS in Nivolumab Treated Non-Small Cell Lung Cancer

被引：1
|
作者：
Wang, X. [1 ]
Barrera, C. [1 ]
Bera, K. [1 ]
Lu, C. [1 ]
Feldman, M. [1 ]
Schalper, K. [2 ]
Rimm, D. [2 ]
Velcheti, V. [3 ]
Madabhushi, A. [1 ]
机构：
[1] Case Western Reserve Univ, Cleveland, OH 44106 USA
[2] Yale Univ, Sch Med, Pathol, New Haven, CT USA
[3] NYU Langone, Perlmutter Canc Ctr, New York, NY USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
predictive image signatures; TILs; response to immunotherapy;
D O I：
10.1016/j.jtho.2019.08.710
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA25.02
引用
收藏
页码：S350 / S351
页数：2
相关论文
共 50 条
  • [31] Combined immunophenotyping of tumor-infiltrating lymphocytes as a prognostic factor in resected patients with non-small cell lung cancer
    Soo, Ross A.
    Asuncion, Bernadette Reyna
    Loh, Marie
    Fazreen, Zul
    Sim, Braxton
    Nga, Min En
    Pang, Yin Huei
    Pang, Brendan
    Iacopetta, Barry
    Soong, Richie Chuan Teck
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [32] Tumor-infiltrating lymphocytes make inroads in non–small-cell lung cancer
    Joshua R. Veatch
    Sylvain Simon
    Stanley R. Riddell
    Nature Medicine, 2021, 27 : 1339 - 1341
  • [33] Tumor-infiltrating lymphocytes predict efficacy of immunotherapy in advanced non-small cell lung cancer: a single-center retrospective cohort study
    Zhang, Wenjie
    Li, Sumei
    Zhang, Chufeng
    Mu, Zhengshuai
    Chen, Kaili
    Xu, Zhenshu
    ACTA ONCOLOGICA, 2023, 62 (08) : 853 - 860
  • [34] Tumor-infiltrating lymphocytes make inroads in non-small-cell lung cancer
    Veatch, Joshua R.
    Simon, Sylvain
    Riddell, Stanley R.
    NATURE MEDICINE, 2021, 27 (08) : 1339 - 1341
  • [35] A retrospective analysis of non-small cell lung cancer patients treated with nivolumab
    Akagi, Kazumasa
    Honda, Noritaka
    Umeyama, Yasuhiro
    Ogawara, Daiki
    Ikeda, Takaya
    Yamaguchi, Hiroyuki
    Kitazaki, Takeshi
    Nakatomi, Katsumi
    Fukuda, Minoru
    Mukae, Hiroshi
    ANNALS OF ONCOLOGY, 2017, 28
  • [36] Classifying Non-Small Cell Lung Cancer by Status of Programmed Cell Death Ligand 1 and Tumor-Infiltrating Lymphocytes on Tumor Cells
    Cui, Shaohua
    Dong, Lili
    Qian, Jialin
    Ye, Lin
    Jiang, Liyan
    JOURNAL OF CANCER, 2018, 9 (01): : 129 - 134
  • [37] Predicting KRAS G12C subtype from non-small cell lung cancer H&E slides using deep learning
    Soubeyran, I.
    Dubois, R.
    Jacquemin, M.
    Courtet, K.
    Laizet, Y.
    Lucchesi, C.
    Allard, B.
    Rousset, A.
    Jaeger, A.
    Moreira, J.
    Khalifa, E.
    Bonhomme, B.
    Italiano, A.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1048 - S1048
  • [38] Programmed Cell Death Ligand 1 and Neutrophil to Lymphocyte Ratio to Predict Response to Nivolumab in Non-Small Cell Lung Cancer
    Bennati, C.
    D'Arcangelo, M.
    Minuti, G.
    Vecchiarelli, S.
    Landi, L.
    Mazza, V.
    Gili, A.
    Puccetti, M.
    Cappuzzo, F.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2390 - S2391
  • [39] Fluorodeoxyglucose uptake is associated with low tumor-infiltrating lymphocyte levels in patients with small cell lung cancer
    Kasahara, Norimitsu
    Kaira, Kyoichi
    Yamaguchi, Koichi
    Masubuchi, Hiroaki
    Tsurumaki, Hiroaki
    Hara, Kenichiro
    Koga, Yasuhiko
    Sakurai, Reiko
    Higuchi, Tetsuya
    Handa, Tadashi
    Oyama, Tetsunari
    Yokobori, Takehiko
    Shimizu, Kimihiro
    Asao, Takayuki
    Hisada, Takeshi
    LUNG CANCER, 2019, 134 : 180 - 186
  • [40] Early Response of Circulating Tumor DNA Predict the Efficacy of Nivolumab in Patients with Non-small Cell Lung Cancer
    Iijima, Yuki
    Hirotsu, Yosuke
    Amemiya, Kenji
    Mochizuki, Hitoshi
    Oyama, Toshio
    Nakagomi, Takahiro
    Uchida, Yoshinori
    Kobayashi, Yoichi
    Tsutsui, Toshiharu
    Kakizaki, Yumiko
    Goto, Taichiro
    Miyashita, Yoshihiro
    Omata, Masao
    CANCER SCIENCE, 2018, 109 : 920 - 920
12345